Kynam Capital Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001907884

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2026 · 37 positions · Total reported value $1.55B · Top-10 concentration 73.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 48.8% · 4 new · 7 cut · 9 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +14.0% · vs SPY -0.8% · Prev Value $1.55B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2026 13F filing, Kynam Capital Management, LP disclosed 37 equity positions with a combined reported value of $1.55B. The filing implies a focused portfolio: its ten largest positions account for 73.4% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were SNDX ($188.07M), CLDX ($185.26M), PCVX ($169.82M). By sector, the heaviest allocations are Health Care 94.3%, Other 5.7%. Versus the prior quarter, allocation shifted toward Other (+0.8pp) and away from Health Care (-0.8pp).

Versus the prior quarter, Kynam Capital Management, LP opened 4 new positions, trimmed 7 and fully exited 9, a turnover rate of 48.8% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q1 2026 were URGN ($40.41M), LEGN ($28.52M), RVMD ($20.18M).

Of the 9 positions fully exited versus the prior quarter, the largest were TYRA ($41.13M), CGON ($39.27M), DVAX ($21.16M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • URGN UROGEN PHARMA LTD · $40.41M
  • LEGN LEGEND BIOTECH CORP SPONSORED ADS · $28.52M
  • RVMD REVOLUTION MEDICINES INC · $20.18M
  • SLNO SOLENO THERAPEUTICS INC · $18.75M
  • CADL CANDEL THERAPEUTICS INC · $980.00K

Fully Exited (vs previous quarter)

  • TYRA TYRA BIOSCIENCES INCORPORATED · prev qtr: $41.13M
  • CGON CG ONCOLOGY INC · prev qtr: $39.27M
  • DVAX DYNAVAX TECHNOLOGIES CORP · prev qtr: $21.16M
  • OMER OMEROS CORP · prev qtr: $3.44M

Insider Transactions (Form 4)

Latest Kynam Capital Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Kynam Capital Management, LP files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 32 positions worth $1.81B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • SEC registration: 801-126187 (status: Approved), registered 2022-07-22
  • Regulatory AUM (Form ADV): $2.41B as of 2026-04-10
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 32 positions · $1.81B reported value (Q2 2026)
  • Top 10 holdings = 72.7% of reported value
  • Largest position: CLDX (CELLDEX THERAPEUTICS INC NEW) at 10.9%
  • Average position size: $56.54M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 12 added, 7 reduced, 9 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 94.3%
Other 5.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.05M $188.07M 12.13%
12.13%
Hold
2 5.84M $185.26M 11.95%
11.95%
Reduce
3 2.92M $169.82M 10.95%
10.95%
Hold
4 4.04M $155.40M 10.02%
10.02%
Reduce
5 3.40M $136.71M 8.82%
8.82%
Reduce
6 3.68M $87.75M 5.66%
5.66%
Add
7 15.01M $70.56M 4.55%
4.55%
Add
8 5.68M $54.08M 3.49%
3.49%
Reduce
9 2.34M $45.80M 2.95%
2.95%
Add
10 3.11M $44.25M 2.85%
2.85%
Hold
11 2.25M $40.41M 2.61%
2.61%
New
12 1.82M $36.66M 2.36%
2.36%
Add
13 825.00K $33.19M 2.14%
2.14%
Reduce
14 1.58M $28.52M 1.84%
1.84%
New
15 934.80K $27.90M 1.80%
1.80%
Hold
16 884.94K $26.68M 1.72%
1.72%
Add
17 872.56K $21.74M 1.40%
1.40%
Add
18 207.50K $20.18M 1.30%
1.30%
New
19 1.23M $19.79M 1.28%
1.28%
Add
20 560.00K $18.75M 1.21%
1.21%
New
21 1.19M $18.52M 1.19%
1.19%
Reduce
22 640.39K $18.09M 1.17%
1.17%
Hold
23 625.50K $14.38M 0.93%
0.93%
Add
24 1.42M $14.17M 0.91%
0.91%
Hold
25 6.84M $10.19M 0.66%
0.66%
Add
26 1.36M $9.24M 0.60%
0.60%
Reduce
27 784.61K $8.35M 0.54%
0.54%
Hold
28 965.19K $7.00M 0.45%
0.45%
Reduce
29 1.00M $6.87M 0.44%
0.44%
Reduce
30 472.38K $6.83M 0.44%
0.44%
Add
31 702.88K $5.95M 0.38%
0.38%
Hold
32 1.59M $5.45M 0.35%
0.35%
Add
33 2.50M $4.76M 0.31%
0.31%
Hold
34 2.00M $4.30M 0.28%
0.28%
Hold
35 1.57M $2.54M 0.16%
0.16%
Hold
36 54.90K $1.63M 0.10%
0.10%
Reduce
37 200.00K $980.00K 0.06%
0.06%
New

FAQ

What did Kynam Capital Management, LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Kynam Capital Management, LP reported 37 equity positions worth $1.55B in aggregate; its largest disclosed positions were SNDX ($188.07M), CLDX ($185.26M), PCVX ($169.82M).

How large is Kynam Capital Management, LP's portfolio?

Kynam Capital Management, LP reported $1.55B of long equity holdings across 37 positions as of 2026-Q1. Top-10 holdings account for 73.4% of reported value.

What is Kynam Capital Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/kynam-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →